Sorci-Thomas M G, Curtiss L, Parks J S, Thomas M J, Kearns M W, Landrum M
Department of Pathology and Comparative Medicine, Wake Forest University School of Medicine, Winston-Salen, North Carolina 27157, USA.
J Biol Chem. 1998 May 8;273(19):11776-82. doi: 10.1074/jbc.273.19.11776.
Apolipoprotein A-I (apoA-I) activates the plasma enzyme lecithin:cholesterol acyltransferase (LCAT), catalyzing the rapid conversion of lipoprotein cholesterol to cholesterol ester. Structural mutants of apoA-I have been used to study the details of apoA-I-LCAT-catalyzed cholesterol ester formation. Several studies have shown that the alpha-helical segments corresponding to amino acids 143-164 and 165-186 (repeats 6 and 7) are essential for LCAT activation. In the present studies, we examined how the orientation of the hydrophobic face, independent of an increase in overall hydrophobicity, affects LCAT activation. We designed, expressed, and characterized a mutant, reverse of 6 apoA-I (RO6 apoA-I), in which the primary amino acid sequence of repeat 6 (amino acids 143-164) was reversed from its normal orientation. This mutation rotates the hydrophobic face of repeat 6 approximately 80 degrees. Lipid-free RO6 apoA-I showed a marked stabilization when denatured by guanidine hydrochloride, but showed significant destabilization to guanidine hydrochloride denaturation in the lipid-bound state compared with wild-type apoA-I. Recombinant high density lipoprotein discs (rHDL) formed from RO6 apoA-I, sn-1-palmitoyl-sn-2-oleoyl phosphati-dylcholine, and cholesterol were approximately 12 A smaller than wild-type apoA-I rHDL. The reduced size suggests that one of the repeats did not effectively participate in phospholipid binding and organization. The sn-1-palmitoyl-sn-2-oleoyl phosphatidylcholine RO6 rHDL were a less effective substrate for LCAT. Mapping the entire lipid-free and lipid-bound RO6 apoA-I with a series of monoclonal antibodies revealed that both the lipid-free and lipid-bound RO6 apoA-I displayed altered or absent epitopes in domains within and adjacent to repeat 6. Together, these results suggest that the proper alignment and orientation of the hydrophobic face of repeat 6 is an important determinant for maintaining and stabilizing helix-bilayer and helix-helix interactions.
载脂蛋白A-I(apoA-I)可激活血浆酶卵磷脂胆固醇酰基转移酶(LCAT),催化脂蛋白胆固醇快速转化为胆固醇酯。apoA-I的结构突变体已被用于研究apoA-I-LCAT催化胆固醇酯形成的细节。多项研究表明,对应于氨基酸143-164和165-186(重复序列6和7)的α-螺旋片段对LCAT激活至关重要。在本研究中,我们研究了疏水面的方向如何在不增加整体疏水性的情况下影响LCAT激活。我们设计、表达并表征了一种突变体,即6号apoA-I反向突变体(RO6 apoA-I),其中重复序列6(氨基酸143-164)的一级氨基酸序列与其正常方向相反。这种突变使重复序列6的疏水面旋转了约80度。无脂RO6 apoA-I在盐酸胍变性时表现出明显的稳定性,但与野生型apoA-I相比,在脂质结合状态下对盐酸胍变性表现出明显的不稳定。由RO6 apoA-I、sn-1-棕榈酰-sn-2-油酰磷脂酰胆碱和胆固醇形成的重组高密度脂蛋白盘(rHDL)比野生型apoA-I rHDL小约12埃。尺寸减小表明其中一个重复序列没有有效地参与磷脂结合和组织。sn-1-棕榈酰-sn-2-油酰磷脂酰胆碱RO6 rHDL作为LCAT的底物效率较低。用一系列单克隆抗体对整个无脂和脂质结合的RO6 apoA-I进行定位显示,无脂和脂质结合的RO6 apoA-I在重复序列6内和相邻区域的结构域中均显示出表位改变或缺失。总之,这些结果表明重复序列6疏水面的正确排列和方向是维持和稳定螺旋-双层和螺旋-螺旋相互作用的重要决定因素。